[CLDX] YoY Quarter Result on 31-Mar-2020 [#Q1]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
06-May-2020
Financial Year
2020
Quarter
31-Mar-2020 [#Q1]
Profit Trend
QoQ- -20.85%
YoY- 26.76%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
Revenue 967 174 685 2,728 1,425 4,068 1,534 -7.39%
PBT -29,361 -23,050 -16,538 -12,625 -17,239 -118,897 -34,261 -2.53%
Tax -6,946 -1,486 764 -16 5,234 -765 5,098 -
NP -22,415 -21,564 -16,538 -12,625 -17,239 -118,132 -34,261 -6.82%
Tax Rate - - - - - - - -
Total Cost 23,382 21,738 17,223 15,353 18,664 122,200 35,795 -6.84%
Ratio Analysis
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
NP Margin -2,317.99 -12,393.10 -2,414.31 -462.79 -1,209.75 -2,903.93 -2,233.44 0.62%
Per Share
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
EPS -0.47 -0.46 -0.42 -0.73 -1.40 -12.61 -4.19 -30.54%
EPS Diluted -0.47 -0.46 -0.42 -0.73 -1.40 -12.61 -4.19 -30.54%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.